Showing results (1141-1150 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|July 17, 2009
Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteersEva M Peñas-LLedó, Pedro Dorado, Rodrigo Pacheco, et al.
Pharmacogenomics|July 17, 2009
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancerSun-Young Kong, Hyeong-Seok Lim, Byung-Ho Nam, et al.
Pharmacogenomics|July 17, 2009
Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain managementPaul J Jannetto, Nancy C Bratanow
Pharmacogenomics|September 19, 2009
Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysisMao Mao, Alice Matimba, Maria G Scordo, et al.
Pharmacogenomics|June 4, 2011
Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black populationCathrine Mitchell, Nerine Gregersen, Amanda Krause
Pharmacogenomics|May 24, 2011
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogeneticsDaniel Sehrt, Ingolf Meineke, Mladen Tzvetkov, et al.
Pharmacogenomics|December 23, 2011
Biomarker classifiers for identifying susceptible subpopulations for treatment decisionsWei-Jiun Lin, James J Chen
Pharmacogenomics|January 18, 2012
Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolismWei Zhang, Wei-Juan Zhang, Jin Zhu, et al.
Pharmacogenomics|January 20, 2012
Genomic approach towards personalized anticancer drug therapyYutaka Midorikawa, Shingo Tsuji, Tadatoshi Takayama, et al.
Pharmacogenomics|November 29, 2011
Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applicationsBritt I Drögemöller, Galen E B Wright, Dana J H Niehaus, et al.
Pageof 276